Veeva Systems (NYSE: VEEV) today announced that the Lymphoma Academic Research Organization (LYSARC) selected Veeva Development Cloud to improve operational efficiency across its lymphoma therapy research. LYSARC will use applications in Vault Clinical, Vault Quality, and Vault Safety suites to build a robust, connected technology foundation that enables faster execution, higher quality data, and better trial oversight.
https://finance.yahoo.com/news/lysarc-partners-veeva-accelerate-innovation-120300448.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.